Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on COVID-19

Study confirms Covid vaccines did not increase mortality rates in France

Covid-19 vaccines did not lead to higher death rates in France, according to a new study using data from 30 million adults. Researchers found that those who were not vaccinated had a 50 percent higher death rate over the four years following the rollout of the vaccines than those who…

Radio France Internationale

CDC advisers delay vote on restricting infant hepatitis B vaccinations in tense meeting

From 1990 to 2019, reported cases of acute hepatitis B among kids declined by 99% due to infant immunization

The Guardian - US

‘Never seen anything like this’: alarm at memo from top US vaccine official

Vinay Prasad memo said at least 10 children had died from Covid vaccination – but offered scant evidence for claim

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

‘Doctors said my dad would be ok after getting Covid. It turned out his illness was terminal’

Father-of seven William Chapman only discovered he had deadly pulmonary fibrosis when his GP – who thought he already knew his prognosis – mentioned it during a phone call

The Independent UK

A dozen former FDA leaders lambast claims by current FDA vaccine chief

A dozen prior leaders of the U.S. Food and Drug Administration issued a scathing denunciation of an FDA memo to staff that made sweeping claims casting doubt on vaccine safety

The Independent UK

Whooping cough vaccine breakthrough after UK outbreak kills 11 babies

The vaccine could offer better protection and stop the virus spreading, scientists say

Evening Standard

‘Breakthrough’ whooping cough vaccine offers new hope after spike in cases

A nasal spray vaccine could be key to stopping the virus from spreading

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Misinformation blamed as Australian vaccine rates slide

Australians are being urged to rebuild their trust in vaccines amid a growing "anti-science sentiment" and falling vaccination rates.

AAP

FDA Vaccine Chief Claims COVID Shots Linked to 'At Least 10' Child Deaths but Offers No Data

US FDA's vaccine director Dr. Vinay Prasad wrote a memo to their staff that claimed multiple child deaths were related to COVID-19 vaccines without data to back it up.

International Business Times UK

Experts say strict new FDA protocol for vaccine approval is ‘dangerous and irresponsible’

Lead FDA vaccine regulator announced new approval process after claiming Covid vaccine had killed 10 children

The Guardian - US

Top FDA official threatens to crack down on vaccine approvals

The internal memo comes after an internal agency review linked COVID-19 vaccines to the deaths of 10 children.

Axios

Louisiana official who called Covid-19 vaccines ‘dangerous’ given key CDC post

Ralph Abraham appointed deputy director as RFK Jr continues to reshape US federal health leadership

The Guardian - US

Sarepta Secures FDA Nod For Elevidys Study To Reduce Liver Injury Risk

The U.S. Food and Drug Administration (FDA) on Tuesday approved dosing in Sarepta Therapeutics Inc.’s (NASDAQ:SRPT) Cohort 8 of ENDEAVOR (Study 9001-103).

Benzinga

Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study

Bayer AG (OTC:BAYRY) released topline results from the Phase 3 OCEANIC-STROKE study, with its investigational, once daily, oral FXIa inhibitor asundexian.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times UK

Harvard Study Reveals Eight Distinct Long Covid Trajectories as 20M Americans Still Battle Symptoms

Harvard researchers have identified eight long COVID trajectories in a major NIH-backed study, offering new insight into how symptoms change over 15 months.

Axios

There are 8 patterns for long COVID symptoms. Here's what they are

Findings come from the NIH-backed RECOVER Initiative.

Benzinga

Contineum Therapeutics' Multiple Sclerosis Trial Disappoints, But Analyst Sees Other Assets Driving Value

Contineum Therapeutics, Inc. (NASDAQ:CTNM) on Thursday shared topline data from its Phase 2 VISTA trial of PIPE-307, an M1 receptor antagonist for relapsing-remitting multiple sclerosis (RRMS).

The Independent UK

Deadly mpox variant Clade 1b spreads in Europe amid rush for vaccines

Mpox cases continue to rise in parts of Africa, three years after a major outbreak infected nearly 100,000 people

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

Nearly 6,000 Londoners died due to Covid within weeks after 'deadly delay' in ordering lockdown

Boris Johnson’s government was slammed by the Covid Inquiry for its ‘chaos’ and the ‘toxic’ culture in No10

The Independent UK

Ozempic could redefine Thanksgiving across the country as users’ appetites dwindle: ‘I don’t want to hurt anyone’s feelings’

‘I will just grab the dish and not eat it,’ one GLP-1 medication user said of her favorite Thanksgiving dish

The Guardian - US

Disease fears as Argentina child vaccination rates hit historic lows

Sharp drop since 2024 in country regarded as a Latin American leader in childhood and adolescent immunisation

The Independent UK

Strange changes found in blood of long Covid patients

Tiny clots appeared larger-than-normal in long Covid patients, study finds

The Independent UK

‘The White Lotus’ saw a surge in searches for one anxiety drug. Doctors give a stark warning

Taking lorazepam and drinking, like characters did on the show, can put people into a coma, doctors warn

Benzinga

This Undervalued Biotech Might Have Just Proven Its Star Drug's Staying Power

On Wednesday, Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) announced data from a post hoc analysis of the GALE extension study following five years of continuous treatment with Syfovre (pegcetacoplan injection) for geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

Benzinga

AnaptysBio To Save $10 Million After Discontinuing Ulcerative Colitis Study

AnaptysBio Inc. (NASDAQ:ANAB) on Monday released data from the Phase 2 trial of rosnilimab for moderate-to-severe ulcerative colitis.

1 … 9 10 11 12

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Harvard Medical School

136 stories

130 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.